Cardiovascular diseases, lipid-lowering therapies and European registries in the COVID-19 pandemic

Cardiovasc Res. 2020 Aug 1;116(10):e122-e125. doi: 10.1093/cvr/cvaa176.

Henning Morawietz¹, Ulrich Julius², Stefan R Bornstein^{3

4}

¹ Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
² Lipidology and Lipoprotein Apheresis Center, Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
³ Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁴ Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

No abstract available

Keywords: COVID-19; CRP; Cardiovascular diseases; Lipoprotein apheresis; Statins.

Publication types